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Background: Biomedical research is increasingly globalized with ever more research conducted in low and middle-
income countries. This trend raises a host of ethical concerns and critiques. While community engagement (CE) has
been proposed as an ethically important practice for global biomedical research, there is no agreement about what
these practices contribute to the ethics of research, or when they are needed.
Discussion: In this paper, we propose an ethical framework for CE. The framework is grounded in the insight that
relationships between the researcher and the community extend beyond the normal bounds of the researcher-research
participant encounter and are the foundation of meaningful engagement. These relationships create an essential “human
infrastructure” – a web of relationships between researchers and the stakeholder community—i.e., the diverse
stakeholders who have interests in the conduct and/or outcomes of the research. Through these relationships,
researchers are able to address three core ethical responsibilities: (1) identifying and managing non-obvious risks
and benefits; (2) expanding respect beyond the individual to the stakeholder community; and (3) building legitimacy
for the research project.
Summary: By recognizing the social and political context of biomedical research, CE offers a promising solution to
many seemingly intractable challenges in global health research; however there are increasing concerns about what
makes engagement meaningful. We have responded to those concerns by presenting an ethical framework for CE. This
framework reflects our belief that the value of CE is realized through relationships between researchers and stakeholders,
thereby advancing three distinct ethical goals. Clarity about the aims of researcher-stakeholder relationships helps to
make engagement programs more meaningful, and contributes to greater clarity about when CE should be
recommended or required.
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Biomedical research is increasingly globalized with ever
more research conducted in low- and middle-income
countries (LMICs). But the dominant paradigm remains
essentially unchanged; the majority of funding coming
from funding agencies and foundations in high-income
countries (HIC) to support research programs and pro-
jects run by researchers in HIC institutions who conduct
their research activities in LMIC settings [1]. The “back-
ground conditions”, of global inequality and injustice
frame this research and raise a host of ethical concerns
[2]. These conditions are further amplified by cultural* Correspondence: kingka@smh.ca
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unless otherwise stated.and linguistic differences, a historical legacy of distrust
and exploitation within the research enterprise, and con-
cerns about scientific colonialism [3]. While these back-
ground conditions create significant challenges, they are
challenges that need to be addressed and managed in
the design and conduct of global biomedical research,
which remains an important and fundamentally ethical
pursuit, and essential to inform solutions to some of the
world’s most pressing health problems.
One recurring theme in reporting about international
biomedical research is that there is inadequate opportunity
for research participants and affected communities to
voice their concerns, and for researchers to acknowledge
them and respond constructively [1-7]. Too often, these
concerns go unaddressed and cause breakdowns in crucial
relationships that, in turn, contribute to various types ofis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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petuate the historical injustices described above [8].
We argue that to address these problems, researchers,
sponsors and funders need to invest in the human infra-
structure of global health research: that web of relationships
between researchers and the stakeholder community— the
unique collection of diverse stakeholders who have interests
in the conduct and/or outcomes of a given research project.
Community Engagement (CE) is a promising strategy for
cultivating this infrastructure. CE refers to a set of practices
that help researchers establish and maintain relationships
with the stakeholders to a research program [9]. While CE
has become increasingly common in global health research,
there is concern that the engagement is often not meaning-
ful, particularly when it is mediated solely through Com-
munity Advisory Boards (CABs) [10-14]. To understand
what makes CE meaningful, we have developed a frame-
work to clarify what CE contributes to the ethical quality of
research. Clarity about these ethical goals is critical to both
improving CE practices, and to understanding when these
practices are important to the ethical conduct of research.
To that end, we propose an ethical framework for CE.
The framework is grounded in the insight that relation-
ships between researchers and the community of stake-
holders in a given global health research project are the
foundation of meaningful engagement. We argue that it
is primarily through these relationships that researchers
are able to address three core ethical responsibilities: [1]
identifying and managing non-obvious risks; [2] extend-
ing respect beyond the individual to the stakeholder
community; and [3] building legitimacy for the research
project. Although each of these ethical goals has re-
ceived attention individually in the ethics of research, we
propose that collectively they represent a coherent and
comprehensive framework that clarifies the unique con-
tributions of CE to global health research, and may serve
as a useful reference for the on-going debate about how
to evaluate the quality and impact of CE.Discussion
Ethical goals of community engagement
Identifying and managing non-obvious risks
In current research ethics review procedures, investigators
and Institutional Review Boards (IRBs) must delineate and
minimize risks to participants–including physical, psycho-
logical, social, economic, and legal risks. However, what
constitutes a risk, and which risks are deemed to be ac-
ceptable, and by whom, may not be obvious to remote re-
searchers and their IRBs, who may be unfamiliar with
ethically significant features of the specific research con-
text. Indeed, the nature and distribution of some risks
may not be obvious to potential research participants
themselves [15].Non-obvious risks—by definition—are not conveni-
ently accessible to researchers through casual observa-
tion. For example, awareness of the cultural significance
of blood and biological tissues, and the various ways in
which related research practices might offend a commu-
nity’s deeply-held beliefs about them, [16] and insights
about what research practices might avoid or minimize
the offense, is gained through dialogue and on-going
communications with the stakeholder community [14].
If researchers do not understand the significance or impli-
cations of the research for stakeholders, they may fail to
recognize what interests are at stake, and so may fail to
take the necessary steps to protect those interests, thereby
exposing participants and host communities to unneces-
sary risk [17]. The nature of the relationship between re-
searchers and stakeholders, i.e., the extent to which they
are able to develop a comfortable rapport and confidently
place trust in one another, influences the extent to which
researchers are able to identify non-obvious risks and take
steps to mitigate them. Failure to understand and evaluate
research from the perspective of the stakeholder commu-
nity, including prospective research participants, can also
jeopardize the scientific quality of the research by com-
promising recruitment, retention, and adherence to the
protocol, as well as the acceptability and ultimate adoption
of any technology under development [4].
Extending respect to the stakeholder community
CE is regularly presented as an important mechanism
for researchers to demonstrate respect for communities,
but the precise contribution of CE to respect remains
unclear [10,11,18-20]. We propose that CE respects af-
fected communities by acknowledging what is valuable
or important about research to them, as people, rather
than prospective participants or facilitators of the re-
search project, and then acting in ways that express that
recognition [21,22].
Researchers respect stakeholders by first listening to
them to understand their perspectives about the re-
search and how it may affect their interests, and then
acting in ways that express that recognition. The simple
act of listening is the foundation of respect and at the
heart of what makes CE meaningful. By listening to af-
fected communities, the research team acknowledges the
importance of the various stakeholders, their interests,
and their moral standing to hold researchers morally
accountable for research-related actions, risks, and bur-
dens. Given the historical legacy of colonialism and ex-
ploitation in many host countries, where the interests of
the population were systematically disregarded, listening
to, acknowledging, and being responsive to stakeholders
acquires great significance.
These actions also represent important gestures of re-
spect because they communicate an appreciation, on the
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cover the ways in which their research might affect the
interests of a wide range of stakeholders. In this way, re-
searchers extend the conventional notion of respect for
the autonomy of individual research participants to a
more comprehensive account of respect for the interests
of the host community.
Building legitimacy for the research project
The third ethical goal of CE is to build legitimacy for the
research project. Legitimacy is a political concern about
the justification of authority over groups of people [23].
It emerges as a concern for biomedical research with the
recognition that research activities usually affect the in-
terests of parties beyond the direct research participants,
yet despite this broad reach, there are currently no set
mechanisms to gauge the relevance or strength of these
interests, or to be responsive to them. A range of consid-
erations contribute to the legitimacy of a research pro-
ject in the eyes of its stakeholders: the perceived social
value of the research; the nature and extent of risks im-
posed on the community; the perceived trustworthiness of
the researchers, sponsoring institutions and funders; the
transparency with which the research is conducted; and
the mechanisms of accountability between the research
team and the affected community. CE contributes to each
of these considerations by building the infrastructure
needed to connect researchers and stakeholders, and it is
through these relationships that concerns of legitimacy
can be addressed [10,11,18-20,22].
Legitimacy is built through both formal and informal
processes. Formally, research must be reviewed and ap-
proved by regulatory authorities such as Research Ethics
Committees. Informally, a project’s legitimacy is built
largely through deliberation and discussion with stake-
holders, including collaborations, institutional partners,
various levels of government, local residents, informal
authorities and anyone whose interests stand to be af-
fected by the proposed research.
Through informal deliberative processes, stakeholders
and researchers engage in the give-and-take of reasons
around the important issues surrounding the project and
the ultimate course of action can be properly justified to
the parties involved [23]. Not all stakeholders can or
must be involved in decisions in order to make them le-
gitimate, nor is it necessary that all stakeholders interact
in a common forum [23]. What is important, rather, is
that there be meaningful efforts to understand the inter-
ests at stake for various stakeholders, and processes in
place to air disagreements and discuss the concerns and
interests of the stakeholder community.
The goal of such discussions is not to resolve all dis-
agreement and reach consensus around the research.
Given the diversity of stakeholders involved, completeconsensus is unlikely. Rather, CE embodies a democratic
ideal in which legitimacy emerges from deliberative pro-
cesses through which disagreement is acknowledged and
addressed, lines of accountability are established between
the stakeholder community and researchers, and stake-
holders are empowered to ask directly for justification
regarding the trial’s conduct and management.
Recent open-release trials of genetically-modified mos-
quitoes to control Dengue virus transmission highlight
the importance of differentiating the legitimacy that is
achieved through the endorsement of formal and infor-
mal authorities in a research community. The approval
of trials by legitimate government authorities, with lim-
ited consultation or engagement with other stakeholders
in the host community, was severely criticized by a wide
range of stakeholders. The stakeholders argued that gov-
ernment approval alone was insufficient for the trial to
go forward as it did not adequately address the risks and
benefits of the trial for different stakeholders [24]. These
objections had enormous impact on public opinion
about the trial and the authority of the government to
approve the research independent of meaningful engage-
ment with the wider public [25].
Community engagement creates human infrastructure for
biomedical research
The three ethical goals, described above, represent im-
portant ethical considerations that are not currently
reflected in most research ethics guidelines and regula-
tions governing global health research. Most notably,
they are distinct in their emphasis on the perspective of
stakeholders, as opposed to the institutional perspective
of the committees or regulatory bodies reviewing the re-
search. While informed consent begins to address the in-
terests of research participants through the disclosure of
materially relevant information and due attention to ad-
equate comprehension and voluntariness, it is not de-
signed to address the full range of legitimate interests in
the trial. It seldom extends beyond the highly structured
and managed interactions of the consent processes, and
does not attempt to elicit the prospective research partici-
pants’ perspectives about the research more broadly, i.e.,
beyond the immediate implications of their participation,
to the implications for their lives and their communities.
However, in drawing attention to these broader interests
of the research community, CE may also offer insights that
could be used to strengthen individual informed consent.
But the range of interests at stake in any research pro-
ject go beyond those of the individual research partici-
pants, and therefore the relationships relevant to global
health research extend beyond those between researchers
and research participants as currently defined by regula-
tions. If the ethical goals for CE, described above, reflect
important ethical considerations that cannot be met
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sent alone, then researchers have a responsibility to estab-
lish relationships with the stakeholder community, which
consists of those individuals or groups of individuals who
have some interest or “stakes” in the research. Whereas
the emphasis in research ethics has been squarely on risks
and potential benefits associated with participation in re-
search, with only limited attention to implications for
“third parties”, this does not exhaust the full range of in-
terests that are brought into play when a research project
is undertaken in a host community.
Many groups and individuals will have interests at stake
in the conduct and/or outcomes of a given research pro-
ject, and not all can be actively engaged. A central task of
CE is to identify the range of stakeholders for a given
study, evaluate their potential interests, and prioritize
whom to engage. Initially, that prioritization is informed
by how and to what extent the proposed research will
affect a stakeholder’s interests. The more significantly re-
search affects the interests of a given stakeholder, the
higher the priority of engaging that stakeholder. In
addition, the responsibility to avoid harming others is gen-
erally stronger than the obligation to benefit them, so pri-
ority is given to engagement with stakeholders at risk of
harm from the research. Inevitably, the manner and extent
of engagement with each party will be subject to practical
limits, including geographic dispersal and budgetary con-
straints [18].
This concept of the stakeholder community is broader
than the traditional view of community in biomedical re-
search, which has focused on pre-existing associations of
individuals such as those living in the same geographic
area, or sharing an ethnic, cultural, religious or occupa-
tional identity [26]. Pre-existing associations are only one
way in which the interests of individuals collect. For any
given research project, individual stakeholders may have
dramatically different interests at stake in its conduct and/
or outcomes, but the fact that each holds some interests
defines the stakeholder community, and grounds the
moral responsibility for engagement. CE creates the hu-
man infrastructure necessary to support the deliberations
and discussions that are necessary to discover, and to be
responsive to, this range of interests.
Summary
CE offers a promising solution to many seemingly intract-
able challenges in global health research by creating the
infrastructure that allows researcher to engage with the
social and political context of biomedical research. Despite
this promise, there are concerns about what makes en-
gagement meaningful [10-14]. We have responded to
those concerns by presenting an ethical framework for CE.
We argue that the ethical value of CE lies in its contribu-
tion to: identifying, and facilitating responsiveness to, non-obvious risks; extending respect beyond individual re-
search participants to the community of stakeholders,
whose interests may be affected; and to building the legit-
imacy of the research project. We argue further that these
ethical goals are realized primarily through a human infra-
structure of relationships between researchers and stake-
holders. There is on-going uncertainty about when CE
should be recommended or required for the ethical con-
duct of research, [10,11] an issue for which there remains
frustratingly little guidance, in particular, for research eth-
ics committees. CE activities, being resource-intensive,
may not be necessary or feasible for many research pro-
jects, and issues of scale and efficiency are yet to be
worked out. Nonetheless, the framework presented here
advances that conversation by identifying the kinds of cir-
cumstances in which CE is important for the ethical con-
duct of research.
More specifically, this framework advances the theory
and practice of community engagement in three key
ways. First, it improves mindfulness among funders, in-
vestigators, research ethics committees, and relevant
regulatory authorities about what CE practices aim to
accomplish ethically, by improving the specificity and
precision of the stated ethical goals. There is no shortage
of literature addressing ethical aspects and implications
of CE. CE has received extensive attention in many
fields—e.g., anthropology, sociology, social psychology,
environmental management, forestry, global health, glo-
bal development, community-based participatory re-
search, feminist philosophy, public engagement for new
technology assessment, public health practice, and social
network theory, among many others. Despite this rich
and extensive literature, however, the specific ethical
contribution of CE remains unclear [11]. By distilling
these insights, the current framework aims to improve
the ability of teams to plan, implement and review CE.
Second, our framework helps research funders justify
the allocation of funds to CE in research proposals by
clarifying the potential value of the investment. Cur-
rently, there is little, if any, public discussion about how,
and to what extent, CE should be funded, and no publicly
available data—to the best of our knowledge—about costs
associated with successful CE practices in research. Clari-
fying the ethical value proposition for CE might help move
this issue forward on the research policy agenda. Third,
our framework can make a modest contribution towards
improving partnerships with host communities, by provid-
ing those communities with greater specificity and preci-
sion about what CE practices aim to achieve.
While this framework focuses on the goals of CE, it
also sheds light on the question of when CE is important
to the ethical conduct of research. In particular, this
framework suggests that CE should be strongly consid-
ered when the conduct and outcomes of the proposed
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are not direct research participants. The greater the reach
of the research beyond research participants, the greater
the need for CE. Research projects vary in the extent to
which they might affect the interests of parties beyond re-
search participants. Certain kinds of trials, such as cluster-
randomized trials, or trials of new broad-based public
health interventions (e.g., insect vector control strategies),
[27] reach far into the community, beyond individual re-
search participants, and thereby warrant special attention
in the form of CE. Of course, the need for CE is often
identified in retrospect, after unforeseen harms have oc-
curred, but having a framework that conceptualizes the
contributions of CE more clearly may also help clarify the
appropriate context of application.
Although we focus, in this paper, on global health re-
search, we believe that these ethical goals of CE apply in
any geographic setting. The ethical goals reflect quite
fundamental human concerns and, therefore, we expect
that they would not be easily subverted by cultural or
political considerations. Indeed, in our own work, we
have studied cases of CE in Canada and Australia in
which these goals would clearly have been applicable.
CE represents an important means of improving both
the ethics and practice of global biomedical research.
Our effort to clarify the ethical goals of CE and to ex-
plore its contribution to the ethical conduct of research
represent a first step in improving the recognition that
biomedical research programs are ultimately human en-
deavors, and that a strong human infrastructure is crit-
ical to both their ethical and practical success.
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